Summary
1. Tardive dyskinesia is more important in postmenopausal women than men of comparable age and a peak of first episodes of schizophrenia is observed in postmenopausal women. The effect of ovariectomy (2 weeks or 3 months) in rats was investigated as a model of decreased gonadal function associated with menopause.
2. Frontal cortex D1 receptor density and affinity were similar in intact male compared to intact female rats and progressively decreased in density with time after ovariectomy, with no change of affinity. Striatal D1 and D2 receptors also decreased in density after ovariectomy for both receptor subtypes, with no change of affinity. Striatal D1 receptor density and affinity were similar in intact male and female rats, whereas the density of D2 receptors was higher in females. Treatment with estradiol for 2 weeks restored the D2 but not the D1 receptor changes.
3. In the substantia nigra pars reticulata, striatum, nucleus accumbens, and entopeduncular nucleus, a progressive increase in [3H]flunitrazepam specific binding associated with GABAA receptors was observed as a function of time following ovariectomy; this was corrected with estradiol treatment. In contrast, the opposite was observed for [3H] flunitrazepam binding in the globus pallidus, where ovariectomy decreased binding, which was corrected with estradiol replacement therapy.
4. Low prefrontal cortex dopamine activity with implications of D1 receptors in negative symptoms of schizophrenia is hypothesized. Furthermore, GABAergic overactivity in the internal globus pallidus-substantia nigra pars reticulata complex is hypothesized in tardive dyskinesia.
5. The present data suggest that gonadal hormone withdrawal by reducing brain dopamine receptors and producing an imbalance of GABAA receptors in the output pathways of the striatum may predispose to schizophrenia and dyskinesia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders.Trends Neurosci. 12366–375.
Angermeyer, M. C. (1982). The association between family atmosphere and hospital. Career of schizophrenic patients.Br. J. Psychiat. 1411–11.
Angermeyer, M. C., and Kühn, L. (1988). Gender differences in age at onset of schizophrenia: An overview.Eur. Arch. Psychiatry Neurol. Sci. 237351–364.
Angermeyer, M. C., Goldstein, J. M., and Kühn, L. (1989). Gender differences in schizophrenia: Rehospitalization and community survival.Psychol. Med. 19365–382.
Bardenstein, K. K., and McGlashan, T. H. (1990). Gender differences in affective, schizoaffective, and schizophreniform disorders. A review.Schizo. Res. 3159–172.
Bédard, P. J., and Boucher, R. (1986). Estradiol can suppress haloperidol-induced supersensitivity in dyskinetic monkeys.Neurosci. Lett. 64206–210.
Calon, F., Goulet, M., Blanchet, P., Martel, J.-C., Bédard, P. J., and Di Paolo, T. (1994). GABAA receptor supersensitivity in the internal segment of the globus pallidus following chronic treatment with a D2 agonist (U-91356A) or Levodopa of MPTP-treated monkeys.17th Annual Meeting of the CCNP, Quebec City, Quebec, Canada, p. 15.
Canonaco, M., Valenti, A., Bettini, E., and Maggi, A. (1989). Differential modulation of [3H]flunitrazepam binding in female rat brain by sex steroid hormones.Eur. J. Pharmacol. 17095–99.
Canonaco, M., Carelli, A., and Maggi, A. (1993). Steroid hormones and receptors of the GABAA supramolecular complex. I. Benzodiazepine receptor level changes in some extrahypothalamic brain areas of the female rat following sex steroid treatment.Neuroendocrinology 57965–973.
Childers, S. E., and Harding, C. M. (1990). Gender, premorbid social functioning and long-term outcome in DMS-III schizophrenia.Schiz. Bull. 16309–318.
Crane, G. E., and Naranjo, E. R. (1971). Motor disorders induced by neuroleptics: A proposed new classification.Arch. Gen. Psychiatry 24179–184.
Crossman, A. R. (1990). A hypothesis on the pathological mechanism that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment.Movement Dis. 5100–108.
Davis, K. L., Kahn, R. S., Ko, G., and Davidson, M. (1991). Dopamine in schizophrenia: A review and reconceptualization.Am. J. Psychiatry 1481474–1486.
Deister, A., and Marneros, A. (1993). Sex-dependent differences in endogenous psychosis. A comparison between schizophrenic, schizo-affective and affective psychoses.Fortsch. Neurol. Psychiatrie 60407–419.
DeLong, M. R. (1990). Primate models of movement disorder of basal ganglia origin.Trends Neurosci. 13281–285.
Diana, M., and Collu, M. (1990). D1 receptors mediated vacuous chewing in the rat: a model of tardive dyskinesia.Pharmacol. Res. 2245.
Di Paolo, T. (1994). Modulation of brain dopamine transmission by sex steroids.Rev. Neurosci. 527–41.
Di Paolo, T., Poyet, P., and Labrie, F. (1982). Effect of prolactin and estradiol on rat striatal dopamine receptors.Life Sci. 312921–2929.
Dworkin, R. H. (1990). Patterns of sex differences in negative symptoms and social functioning consistent with separate dimensions of schizophrenic psychopathology.Am. J. Psychiatry 147347–349.
Farde, L., Wiesel, F. A., Nordstrom, A. L., and Sedvall, G. (1989). D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics.Psychopharmacology 99S28-S31.
Fibiger, H. C., and Lloyd, K. G. (1984). Neurobiological substrates of tardive dyskinesia: The GABA hypothesis.Trends Neurosci. 7462–464.
Fields, J. Z., Wichlinski, L. J., Ritzmann, R. F., Drucker, G. E., and Gordon, J. H. (1991). Cyclo(leu-glu) reverses the permanent dopamine receptor up-regulation induced by ovariectomy.Drug Dev. Res. 23261–268.
Flor-Henry, P. (1985). Schizophrenia: Sex differences.Can. J. Psychiatry 30319–322.
Gerfen, C. R. (1992). The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia.Annu. Rev. Neurosci. 15285–320.
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., and Sibley, D. R. (1990). D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.Science 2501429–1432.
Gerlach, J. (1988). Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.L'Encéphale XIV227–232.
Goldstein, J. M., and Tsuang, M. T. (1990). Gender and schizophrenia: An introduction and synthesis of findings.Schizo. Bull. 16179–183.
Goldstein, J. M., Santangelo, S. L., Simpson, J. C., and Tsuang, M. T. (1990). The role of gender in identifying subtypes of schizophrenia: A latent class analytic approach.Schizo. Bull. 16263–276.
Gomez-Mancilla, B., Boucher, R., Gagnon, C., Di Paolo, T., Markstein, R., and Bédard, P. J. (1993). Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment I. Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.Move. Disord. 8144–150.
Gordon, J. H., and Fields, J. Z. (1989). A permanent dopamine receptor up-regulation in the ovariectomized rat.Pharmacol. Biochem. Behav. 33123–125.
Gureje, O. (1991). Gender and schizophrenia: Age at onset and sociodemographic attributes.Acta Psychiatr. Scand. 83402–405.
Häfner, H., Riecher, A., Maurer, K., Löffler, W., Munk-Jorgensen, P., and Strömgren, E. (1989). How does gender influence age at first hospitalization for schizophrenia? A transnational case register study.Psychol. Med. 19903–908.
Häfner, H., Behrens, S., De Vries, D. J., and Gattaz, W. F. (1991). Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic transmission.Eur. Arch. Psychiatry Clin. Neurosci. 24165–68.
Hambrecht, M., Maurer, K., and Häfner, H. (1992). Evidence for a gender bias in epidemiological studies of schizophrenia.Schizo. Res. 8223–231.
Harrison, M. B., Wiley, R. G., and Wooten, G. F. (1990). Selective localization of striatal D1 receptors to striatonigral neurons.Brain Res. 528317–322.
Iacono, W. G., and Beiser, M. (1992). Where are the women in first-episode studies of schizophrenia?Schizo. Bull. 18471–480.
Jüptner, M., Jussofie, A., and Hiembre, C. (1991). Effects of ovariectomy and steroid replacement on GABAA receptor binding in female rat brain.J. Steroid Biochem. Mol. Biol. 38141–147.
Lévesque, D., and Di Paolo, T. (1990). Effect of the rat estrous cycle at ovariectomy on striatal D1 dopamine receptors.Brain Res. Bull. 24281–284.
Lévesque, D., Gagnon, S., and Di Paolo, T. (1989). Striatal D-1 dopamine receptor density fluctuates during the rat estrous cycle.Neurosci. Lett. 98345–350.
Lewine, R. (1985). Schizophrenia: An amotivational syndrome in men.Can. J. Psychiatry 30316–318.
Loranger, A. W. (1984). Sex difference in age at onset of schizophrenia.Arch. Gen. Psychiatry 41157–161.
Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with folin reagent.J. Biol. Chem. 193265–272.
Marin, C., Parashos, S. A., Kapitzoglou-Logothetis, V., Peppe, A., and Chase, T. N. (1993). D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.Pharmacol. Biochem. Behav. 45195–200.
McCabe, M. S. (1975). Demographic difference in functional psychoses.Br. J. Psychiatry 127320–323.
Nicole, L., Lesage, A., and Lalonde, P. (1992). Lower incidence and increased male: female ratio in schizophrenia.Br. J. Psychiatry 161556–557.
Nordstrom, A. L., Farde, L., Wiesel, F. A., Forslund, K., Pauli, S., Halldin, C., and Uppfeldt, G. (1993). Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients.Biol. Psychiatr. 33227–235.
O'Connor, L. H., Nork, B., and McEwen, B. S. (1988). Regional specificity of gamma-aminobutyric acid receptor regulation by estradiol.Neuroendocrinology 47473–481.
Opjordsmoen, S. (1991). Long-term clinical outcome of schizophrenia with special reference to gender references.Acta Psychiat. Scand. 83307–313.
Penney, M., and Young, P. (1986). Striatal inhomogeneities and basal ganglia function.Move. Dis. 113–16.
Pogue-Giele, M. F., and Zubin, J. (1988). Negative symptomatology and schizophrenia: A conceptual and empirical review.Int. J. Ment. Health 163–45.
Ring, N., Tantam, D., Montague, L., Newby, D., Black, D., and Morris, J. (1991). Gender differences in the incidence of definite schizophrenia and atypical psychosis—focus on negative symptoms of schizophrenia.Acta Psychiat. Scand. 84489–496.
Rosengarten, H., Schweitzer, J. W., and Friedhoff, A. J. (1983). Induction of oral dyskinesias in naive rats by D1 stimulation.Life sci. 332479–2482.
Seeman, M. V. (1982). Gender differences in schizophrenia.Can. J. Psychiatry 27107–112.
Seeman, M. V. (1985). Sex and schizophrenia.Can. J. Psychiatry 30313–315.
Shirakawa, O., Maeda, K., and Sakai, K. (1993). Dysregulation of striato-nigral GABAergic pathway by chronic haloperidol treatment: The role of dopamine D1 receptor in the substantia nigra reticulata on the development of tardive dyskinesia.Jap. J. Psychiatry Neurol. 47429–430.
Surmeier, D. J., Reiner, A., Levine, M. S., and Ariano, M. A. (1993). Are neostriatal dopamine receptors co-localized?Trends Neurosci. 16299–305.
Yassa, R., and Jeste, D. V. (1992). Gender differences in tardive dyskinesia: A critical review of the literature.Schizo. Bull. 18701–715.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bossé, R., Paolo, T.D. The modulation of brain dopamine and GABAA receptors by estradiol: A clue for CNS changes occurring at menopause. Cell Mol Neurobiol 16, 199–212 (1996). https://doi.org/10.1007/BF02088176
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02088176